Cumulative Radiation Exposure from Imaging Procedures and Associated Lifetime Cancer Risk for Patients with Lymphoma

Overview

Journal Sci Rep

Specialty Science

Date 2016 Oct 18

PMID 27748377

Citations 19

Authors

Grete Fabritius

Gunnar Brix

Elke Nekolla

Stefan Klein

Henning D Popp

Mathias Meyer

Gerhard Glatting

Claudia Hagelstein

Wolf K Hofmann

Stefan O Schoenberg

Thomas Henzler

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to systematically evaluate the cumulative radiation exposure and the associated lifetime-cancer-risk from diagnostic imaging in patients with Hodgkin-lymphoma-(HL) or diffuse-large-B-cell-lymphoma (DLBCL). 99 consecutive patients (53-males) diagnosed with HL or DLBCL were included in the study and followed. Based on the imaging reports, organ and effective-doses-(ED) were calculated individually for each patient and the excess lifetime risks were estimated. The average ED in the first year after diagnosis was significantly different for men (59 ± 33 mSv) and women (74 ± 33 mSv)-(p < 0.05). The mean cumulative ED in each of the following 5 years was 16 ± 16 mSv without significant differences between men and women-(p > 0.05). Over all years, more than 90% of the ED resulted from CT. The average cumulative radiation risk estimated for the first year was significantly lower for men (0.76 ± 0.41%) as compared to women (1.28 ± 0.54%)-(p < 0.05). The same was found for each of the subsequent 5-years (men-0.18 ± 0.17%; women-0.28 ± 0.25%)-(p < 0.05). In conclusion, for HL and DLBCL patients investigated in this study, a cumulative radiation risk of about 1 excess cancer per 100 patients is estimated for diagnostic imaging procedures performed during both the first year after diagnosis and a follow-up period of 5 years.

Citing Articles

Potential of photon-counting detector CT technology for contrast medium reduction in portal venous phase thoracoabdominal CT.

Popp D, Siedlecki M, Friedrich L, Haerting M, Scheurig-Muenkler C, Schwarz F Eur Radiol. 2025; .

PMID: 39939421 DOI: 10.1007/s00330-025-11409-3.

Paulini I Z Med Phys. 2024; 34(4):485-489.

PMID: 39419739 PMC: 11624360. DOI: 10.1016/j.zemedi.2024.09.001.

Real time eye dose reduction in fluoroscopy with auditory and visual feedback dosimeter through swine model experiments.

Khan M, Yi B Sci Rep. 2024; 14(1):19319.

PMID: 39164306 PMC: 11335762. DOI: 10.1038/s41598-024-66698-3.

Cumulative radiation exposure from radiological imaging in patients with Hodgkin and diffuse large b-cell lymphoma not submitted to radiotherapy.

Brambilla M, Matheoud R, Margiotta-Casaluci G, Cannillo B, DAlessio A, Siciliano C Br J Radiol. 2023; 96(1149):20230106.

PMID: 37493259 PMC: 10461276. DOI: 10.1259/bjr.20230106.

Low-dose coronary calcium scoring tarnishes power of zero.

Motwani M J Nucl Cardiol. 2023; 30(3):1199-1201.

PMID: 36813933 DOI: 10.1007/s12350-023-03211-9.

References

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP. 2007; 37(2-4):1-332. DOI: 10.1016/j.icrp.2007.10.003. View

Tilly H, Gomes Da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A . Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015; 26 Suppl 5:v116-25. DOI: 10.1093/annonc/mdv304. View

Mayer C, Meyer M, Fink C, Schmidt B, Sedlmair M, Schoenberg S . Potential for radiation dose savings in abdominal and chest CT using automatic tube voltage selection in combination with automatic tube current modulation. AJR Am J Roentgenol. 2014; 203(2):292-9. DOI: 10.2214/AJR.13.11628. View

Meyer M, Klein S, Brix G, Fink C, Pilz L, Jafarov H . Whole-body CT for lymphoma staging: feasibility of halving radiation dose and risk by iterative image reconstruction. Eur J Radiol. 2013; 83(2):315-21. DOI: 10.1016/j.ejrad.2013.11.008. View

Cheson B, Fisher R, Barrington S, Cavalli F, Schwartz L, Zucca E . Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014; 32(27):3059-68. PMC: 4979083. DOI: 10.1200/JCO.2013.54.8800. View

Brix G, Berton M, Nekolla E, Lechel U, Schegerer A, Suselbeck T . Cumulative radiation exposure and cancer risk of patients with ischemic heart diseases from diagnostic and therapeutic imaging procedures. Eur J Radiol. 2013; 82(11):1926-32. DOI: 10.1016/j.ejrad.2013.07.015. View

Puri S, Hu R, Quazi R, Voci S, Veazie P, Block R . Physicians' and midlevel providers' awareness of lifetime radiation-attributable cancer risk associated with commonly performed CT studies: relationship to practice behavior. AJR Am J Roentgenol. 2012; 199(6):1328-36. PMC: 3676280. DOI: 10.2214/AJR.12.8581. View

Amis Jr E, Butler P, Applegate K, Birnbaum S, Brateman L, Hevezi J . American College of Radiology white paper on radiation dose in medicine. J Am Coll Radiol. 2007; 4(5):272-84. DOI: 10.1016/j.jacr.2007.03.002. View

10.

. Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53). Ann ICRP. 2000; 28(3):1-126. DOI: 10.1016/s0146-6453(99)00006-8. View

11.

Shah D, Sachs R, Wilson D . Radiation-induced cancer: a modern view. Br J Radiol. 2012; 85(1020):e1166-73. PMC: 3611719. DOI: 10.1259/bjr/25026140. View

12.

Nievelstein R, Quarles van Ufford H, Kwee T, Bierings M, Ludwig I, Beek F . Radiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma. Eur Radiol. 2012; 22(9):1946-54. PMC: 3411290. DOI: 10.1007/s00330-012-2447-9. View

13.

Eichenauer D, Engert A, Dreyling M . Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011; 22 Suppl 6:vi55-8. DOI: 10.1093/annonc/mdr378. View

14.

Stamm G, Nagel H . [CT-expo--a novel program for dose evaluation in CT]. Rofo. 2002; 174(12):1570-6. DOI: 10.1055/s-2002-35937. View

15.

Stamatoullas A, Brice P, Bouabdallah R, Mareschal S, Camus V, Rahal I . Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly. Br J Haematol. 2015; 170(2):179-84. DOI: 10.1111/bjh.13419. View

16.

Ackerman K, Pober B . Congenital diaphragmatic hernia and pulmonary hypoplasia: new insights from developmental biology and genetics. Am J Med Genet C Semin Med Genet. 2007; 145C(2):105-8. PMC: 2891760. DOI: 10.1002/ajmg.c.30133. View

17.

Picardi M, Pugliese N, Cirillo M, Zeppa P, Cozzolino I, Ciancia G . Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures. Radiology. 2014; 272(1):262-74. DOI: 10.1148/radiol.14132154. View

18.

Shore R . Radiation impacts on human health: certain, fuzzy, and unknown. Health Phys. 2014; 106(2):196-205. DOI: 10.1097/HP.0000000000000021. View

19.

Thompson C, Ghesquieres H, Maurer M, Cerhan J, Biron P, Ansell S . Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma. J Clin Oncol. 2014; 32(31):3506-12. PMC: 4209102. DOI: 10.1200/JCO.2014.55.7561. View